Tempest Therapeutics (TPST) Restructuring Costs (2016 - 2018)
Tempest Therapeutics (TPST) posted Restructuring Costs of $121000.0 for Q4 2018, up 128.3% sequentially from $53000.0 in Q3 2018, and up 107.85% YoY from $58215.9 in Q4 2017.
Tempest Therapeutics (TPST) Restructuring Costs (2016 - 2018) Analysis & Trends
Tempest Therapeutics has reported Restructuring Costs for 3 years, with the latest figure at $121000.0 in Q4 2018.
- Quarterly Restructuring Costs rose 107.85% year-over-year to $121000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $3.8 million (up 61.08% YoY) and the FY2018 annual result came in at $3.8 million, up 63.39% from the prior year.
- Restructuring Costs climbed to $121000.0 in Q4 2018 per TPST's latest filing, from $53000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $5.4 million in Q4 2016 and troughed at -$1.5 million in Q4 2017.
- A 3-year average of $1.3 million and a median of $700000.0 in 2018 frame the typical range for Restructuring Costs.
- The sharpest annual moves came in 2017 and 2018: Restructuring Costs sank 128.56% in 2017, then soared 107.85% in 2018.
- Over 3 years, Restructuring Costs stood at $5.4 million in 2016, then tumbled by 128.56% to -$1.5 million in 2017, then soared by 107.85% to $121000.0 in 2018.
- According to Business Quant data, Restructuring Costs over the past three periods registered $121000.0, $53000.0, and $2.9 million for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 121,000.00 |
| Sep 30, 2018 | 53,000.00 |
| Jun 30, 2018 | 2.89 Mn |
| Mar 31, 2018 | 700,000.00 |
| Dec 31, 2017 | -1.54 Mn |
| Sep 30, 2017 | 400,000.00 |
| Jun 30, 2017 | 1.99 Mn |
| Mar 31, 2017 | 1.49 Mn |
| Dec 31, 2016 | 5.40 Mn |